Skip to main content

Table 1 Top 10 cancer incidence in three life expectancy levels areas of China, 2013

From: Interactions between life expectancy and the incidence and mortality rates of cancer in China: a population-based cluster analysis

Rank Gender Low life expectancy level areas Middle life expectancy level areas High life expectancy level areas
Site Incidence Proportion ASRa Site Incidence Proportion ASRa Site Incidence Proportion ASRa
(1/105) (%) (1/105) (1/105) (%) (1/105) (1/105) (%) (1/105)
0 Both All sites 242.77 100.00 186.91 All sites 262.81 100.00 179.00 All sites 339.61 100.00 192.83
1 Lung 49.39 20.34 37.41 Lung 55.64 21.17 36.88 Lung 66.44 19.56 34.90
2 Stomach 37.50 15.45 28.76 Stomach 32.36 12.31 21.66 Colorectum 38.42 11.31 20.57
3 Liver 29.17 12.01 22.25 Liver 27.42 10.43 18.56 Stomach 31.83 9.37 17.08
4 Esophagus 26.87 11.07 20.58 Esophagus 24.42 9.29 16.27 Breast 56.75 8.35 34.59
5 Colorectum 17.85 7.35 13.60 Colorectum 22.61 8.60 15.12 Liver 28.08 8.27 15.83
6 Breast 28.36 5.67 21.26 Breast 37.05 6.94 25.18 Thyroid 17.54 5.16 12.19
7 Cervix 16.24 3.25 12.19 Thyroid 8.17 3.11 5.89 Esophagus 16.14 4.75 8.55
8 Brain, CNS 6.79 2.80 5.53 Cervix 14.21 2.66 9.71 Pancreas 10.16 2.99 5.21
9 Leukemia 4.83 1.99 4.46 Brain, CNS 6.21 2.36 4.63 Brain, CNS 8.81 2.59 5.82
10 Pancreas 4.03 1.66 3.06 Pancreas 6.10 2.32 4.04 Lymphoma 8.74 2.57 5.21
0 Men All sites 276.05 100.00 220.73 All sites 294.24 100.00 207.57 All sites 365.39 100.00 209.60
1 Lung 65.90 23.87 52.32 Lung 73.76 25.07 51.26 Lung 86.09 23.56 47.22
2 Stomach 51.72 18.74 41.26 Stomach 44.90 15.26 31.41 Colorectum 43.61 11.94 24.27
3 Liver 41.18 14.92 32.42 Liver 39.91 13.56 27.97 Stomach 43.53 11.91 24.21
4 Esophagus 35.64 12.91 28.47 Esophagus 33.74 11.47 23.61 Liver 41.14 11.26 24.16
5 Colorectum 19.84 7.19 15.75 Colorectum 25.67 8.72 17.87 Esophagus 23.95 6.55 13.38
6 Brain, CNS 6.97 2.52 5.79 Bladder 7.81 2.66 5.36 Prostate 16.80 4.60 8.51
7 Bladder 5.37 1.94 4.21 Pancreas 6.95 2.36 4.83 Bladder 13.24 3.62 7.08
8 Leukemia 5.29 1.92 4.97 Prostate 6.72 2.28 4.48 Pancreas 11.26 3.08 6.13
9 Lymphoma 4.72 1.71 3.89 Lymphoma 6.17 2.10 4.53 Kidney 10.23 2.80 6.04
10 Pancreas 4.56 1.65 3.61 Leukemia 6.00 2.04 5.24 Lymphoma 9.96 2.72 6.12
0 Women All sites 207.45 100.00 154.66 All sites 230.36 100.00 152.91 All sites 313.81 100.00 178.58
1 Lung 31.86 15.36 22.94 Breast 37.05 16.08 25.18 Breast 56.75 18.08 34.59
2 Breast 28.36 13.67 21.26 Lung 36.93 16.03 23.28 Lung 46.78 14.91 23.36
3 Stomach 22.41 10.80 16.31 Colorectum 19.46 8.45 12.51 Colorectum 33.24 10.59 17.10
4 Esophagus 17.58 8.47 12.79 Stomach 19.42 8.43 12.32 Thyroid 26.34 8.39 18.22
5 Liver 16.42 7.91 11.98 Esophagus 14.81 6.43 9.18 Stomach 20.13 6.41 10.37
6 Cervix 16.24 7.83 12.19 Liver 14.54 6.31 9.27 Cervix 15.25 4.86 9.74
7 Colorectum 15.73 7.58 11.50 Cervix 14.21 6.17 9.71 Liver 15.02 4.79 7.67
8 Uterus 7.75 3.74 5.84 Thyroid 12.74 5.53 9.12 Uterus 12.02 3.83 7.14
9 Brain, CNS 6.60 3.18 5.28 Uterus 8.31 3.61 5.66 Brain, CNS 9.71 3.09 6.18
10 Ovary 6.12 2.95 4.78 Ovary 7.26 3.15 5.11 Ovary 9.17 2.92 5.77
  1. aASR: age-standardized incidence rate (Segi’s Standard Population)
Back to article page

Cancer Communications

ISSN: 2523-3548

Contact us